DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zonalon (Doxepin Hydrochloride Topical) - Published Studies

 
 



Zonalon Related Published Studies

Well-designed clinical trials related to Zonalon (Doxepin Topical)

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). [2014]

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. [2011.10.01]

Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard. [2011.05]

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. [2010.11]

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. [2010]

Low-dose doxepin for treatment of pruritus in patients on hemodialysis. [2007.07]

A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders. [2007.03]

Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. [2007]

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. [2003.12]

Absolute bioavailability and stereoselective pharmacokinetics of doxepin. [2002.07]

Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. [2001.06]

Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema. [2001.04]

Bioavailability investigation of two different oral formulations of doxepin. [2001]

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. [2000.06]

Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis. [1999.08]

Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients. [1998]

The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin. [1997.09]

On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin. [1997.03]

Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. [1997.02]

Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia. [1996.09]

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. [1995.12]

The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. [1995.12]

A double-blind comparison of moclobemide and doxepin in depressed general practice patients. [1995.08]

The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. [1994.12]

Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. [1994.10]

Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group. [1994.06]

A double-blind comparison of amitriptylinoxide versus doxepine in the treatment of severe depression. [1994.05]

A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients. [1993.08]

A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. [1993.01]

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. [1992.02]

[Intravenous versus oral treatment of endogenously depressed patients with doxepin--a double-blind study with plasma level determination] [1989.11.30]

Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study. [1989.10]

Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin. [1988.07]

Well-designed clinical trials possibly related to Zonalon (Doxepin Topical)

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011]

Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography. [2010.12]

An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. [2010.08]

An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. [2010]

Onset and duration of action of topical antihistamine: a study of histamine skin test response. [2008.08]

Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration. [2003.10]

Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? [2003.05]

Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. [2002.12.20]

Autonomic correlates of antidepressant treatment using heart-rate variability analysis. [1998.03]

[Variation of female migraine after menopause and its prophylaxis and treatment] [1997.07]

Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation. [1997]

Predictors of outcome in panic disorder: a 5-year prospective follow-up study. [1996.11.25]

[Antidepressives and traffic safety] [1994.09]

A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep. [1994]

Is there a role for nonsedating antihistamines in motion sickness? Fallout from space research may soon benefit your patients. [1991.04]

Weight changes on fluoxetine as a function of baseline weight in depressed outpatients. [1990]

Duration of the suppressive effect of tricyclic antidepressants on histamine-induced wheal-and-flare reactions in human skin. [1988.11]

Dysthymia: a randomized study of cognitive marital therapy and antidepressants. [1988.03]

Other research related to Zonalon (Doxepin Topical)

Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study. [2013]

Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. [2012]

A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. [2011.07]

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. [2011]

A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. [2011]

Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard. [2011]

Efficacy and safety of doxepin 6 mg in a model of transient insomnia. [2010.10]

Low-dose doxepin: in the treatment of insomnia. [2010.08.01]

Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia. [2010.03.19]

Hypothermia in a combined intoxication with doxepin and moclobemide in an adolescent. [2010.02.25]

Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis. [2009.12]

Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin. [2009.10]

Doxepin and nordoxepin concentrations in body fluids and tissues in doxepin associated deaths. [2009.09.10]

Low-dose doxepin for the treatment of insomnia: emerging data. [2009.07]

Selective histamine H(1) antagonism: a novel approach to insomnia using low-dose doxepin. [2009.04]

Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice. [2009.03]

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: A randomized, double-blind, placebo-controlled crossover study. [2008.10.07]

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. [2008.10]

Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin. [2008.06]

Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. [2008.03]

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. [2007.11.01]

A fatal doxepin poisoning associated with a defective CYP2D6 genotype. [2007.09]

Novel therapeutic usage of low-dose doxepin hydrochloride. [2007.08]

Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. [2007.03]

Oral doxepin rinse: the analgesic effect and duration of pain reduction in patients with oral mucositis due to cancer therapy. [2006.08]

Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. [2006.01]

Doxepin by topical application and intrathecal route in rats. [2006.01]

Use of reference tissue models for quantification of histamine H1 receptors in human brain by using positron emission tomography and [11c]doxepin. [2005.09]

Simplified PET measurement for evaluating histamine H1 receptors in human brains using [11C]doxepin. [2004.11]

Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. [2004.08]

Doxepin inhibits CYP2D6 activity in vivo. [2004.07]

Quantitative measurement of histamine H(1) receptors in human brains by PET and [11C]doxepin. [2004.02]

Topical application of the tricyclic antidepressant doxepin can reduce dysuria and frequency. [2004]

Systemic contact dermatitis to doxepin. [2003.08]

Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. [2003.02]

Oral topical doxepin rinse: anesthetic effect in normal subjects. [2003.01]

Pharmacokinetics of doxepin and desmethyldoxepin: an evaluation with the population approach. [2002.07]

Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis. [2002.06]

Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. [2001.12]

Elimination of doxepin isomers from the horse following intravenous application. [2001.08]

Doxepin plasma concentrations: is there really a therapeutic range? [2001.08]

Influence of doxepin used in preemptive analgesia on the nociception in the perioperative period. Experimental and clinical study. [2001.05]

Doxepin toxicity in a child following topical administration. [2000.03]

Doxepin incorporated into a dermatologic cream: an assessment of both doxepin antipruritic action and doxepin action as an inhibitor of papules, in allergen and histamine-caused pruritus. [1999.09]

[Toxicologic findings in suicide with doxepin and paroxetine] [1999.07]

Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. [1999.06]

Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy. [1998.10]

Stereoselective in vivo and in vitro studies on the metabolism of doxepin and N-desmethyldoxepin. [1997.12]

[The diffusion and dissolution of metronidazole and doxepin in semisolid pharmaceutical forms through synthetic membranes] [1997.07]

Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system. [1997.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017